Detected ·
Aurenar, Inc
$5.7M—
Aurenar, Inc closed an oversubscribed $5.7M seed financing round co-led by the Go Red for Women Venture Fund (American Heart Association Ventures) and Solas BioVentures, with participation from BJC Health and Kaleida Capital. The funding will accelerate development of their non-invasive neuromodulation platform targeting inflammatory response following stroke and critical illness, coming weeks after receiving FDA Breakthrough Device Designation.
- Website
- www.aurenar.com
- linkedin.com/company/aurenar-inc
- Amount
- $5 700 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-07-29 08:13:16 UTC
- Signal ID
- 2f4f24ee-bda1-4979-9c95-dc964ff99e73
As the API returns it
{
"id": "2f4f24ee-bda1-4979-9c95-dc964ff99e73",
"created_at": "2026-07-29T08:13:16.889066Z",
"company_name": "Aurenar, Inc",
"company_website_url": "www.aurenar.com",
"company_linkedin_url": "https://www.linkedin.com/company/aurenar-inc",
"event_type": "funding",
"funding_amount": 5700000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*Aurenar, Inc closed an oversubscribed $5.7M seed financing round co-led by the Go Red for Women Venture Fund (American Heart Association Ventures) and Solas BioVentures, with participation from BJC Health and Kaleida Capital. The funding will accelerate development of their non-invasive neuromodulation platform targeting inflammatory response following stroke and critical illness, coming weeks after receiving FDA Breakthrough Device Designation.*"
}